1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) - HEAL Initiative. This FOA supports the commercialization of SBIR/STTR-funded pain management technologies by adding experienced entrepreneurs to small business leadership teams and supporting private fundraising and partnership activities.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed) | Research Funding National Institutes of Health HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to facilitate the transition of previously funded SBIR and STTR Phase II and Phase IIB projects in pain management to the commercialization stage by providing additional assistance for private partnering activities through the Commercialization Readiness Pilot (CRP) program.
Specifically, this FOA supports the addition of entrepreneurial expertise into small business leadership teams along with supporting partnering activities to aid in commercialization through private third-party funding or partnership with industry. Clinical trials are not accepted under this FOA.
Letter of Intent Due Date(s): 30 days prior to the application due date Application Due Dates: April 5, 2023; Sep 5, 2023; April 5, 2024; Sep 5, 2024; April 5, 2025; Sep 5, 2025 PAR-23-069 Expiration Date September 06, 2025 Only United States small business concerns (SBCs) that have had an active NIH SBIR or STTR Phase II or Phase IIB contract or grant award from NIH ICs within the last 36 months are eligible to submit applications for this opportunity.
Only one CRP is allowed per Phase II or Phase IIB project. SBCs with currently active and newly awarded Phase II or Phase IIB awards from one of the participating ICs are also eligible.. Total funding support (direct costs, indirect costs, fee) up to $400,000, with no more than $200,000 total cost per year, may be requested.
Applicants are strongly encouraged to contact program officials prior to submitting any application and early in the application planning process . In all cases, applicants should propose a budget that is reasonable and appropriate for completion of the proposed project. Engineering and Physical Sciences Medical - Clinical Science
According to the current listing, eligibility includes: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II or Phase IIb awardees who are focused on advancing pain management therapies and technologies that have been funded by the…. Confirm the full requirements in the official notice before applying.
HEAL Commercialization Readiness Pilot (CRP) Program: Embedded Entrepreneurs for Small Businesses in Pain Management (SB1 Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH) - HEAL Initiative. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article